Bacterial surface properties influence the activity of the TAT-RasGAP317-326 antimicrobial peptide
M. Georgieva, T. Heinonen, A. Vitale, S. Hargraves, S. Causevic, T. Pillonel, L. Eberl, C. Widmann, N. Jacquier
Abstract
Antibiotic resistance is an increasing threat for public health, underscoring the need for new antibacterial agents. Antimicrobial peptides (AMPs) represent an alternative to classical antibiotics. TAT-RasGAP317-326 is a recently described AMP effective against a broad range of bacteria, but little is known about the conditions that may influence its activity. Using RNA-sequencing and screening of mutant libraries, we show that Escherichia coli and Pseudomonas aeruginosa respond to TAT-RasGAP317-326 by regulating metabolic and stress response pathways, possibly implicating two-component systems. Our results also indicate that bacterial surface properties, in particular integrity of the lipopolysaccharide layer, influence peptide binding and entry. Finally, we found differences between bacterial species with respect to their rate of resistance emergence against this peptide. Our findings provide the basis for future investigation on the mode of action of this peptide and its potential clinical use as an antibacterial agent.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vitro synergistic action of TAT-RasGAP317-326 peptide with antibiotics against Gram-negative pathogens
G. Vizzarro, N. Jacquier·Journal of Global Antimicrobial ResistancePeer-reviewed·Dec 1, 2022
- In vitro resistance selection in Acinetobacter baumannii against the antimicrobial peptide TAT-RasGAP317-326 can cause cross-resistance to polymyxins through mutations in pmrAB
Emily Ritz, Tiffany Rossel, Nicolas Jacquier·bioRxiv·Jan 22, 2025
- The antimicrobial peptide TAT-RasGAP317-326 inhibits the formation and the expansion of bacterial biofilms in vitro
T. Heinonen, S. Hargraves, … N. Jacquier·bioRxiv·Sep 29, 2020
- Antimicrobial peptides can generate tolerance by lag and interfere with antimicrobial therapy
D. Sandin Garcia, J. Valle, … M. Torrent Burgas·bioRxiv·Jun 3, 2022
- Novel action of proline-rich antimicrobial peptides Api88, Api137, Onc72 and Onc112 against Pseudomonas aeruginosa and Escherichia coli in ion-rich environments.
Namfon Pantarat, Daniel Knappe, … Neil Martin O’brien-simpson·bioRxiv·May 9, 2025
- Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa
Qingtian Gong, Silvia A. Synowsky, … Clarissa Melo Czekster·ACS Infectious DiseasesPeer-reviewed·Aug 20, 2026